麻豆传媒色情片

Climate Change

CALeDNA: Tracking biodiversity at the molecular level

Jen Elana Quick-Cleveland
Oct. 12, 2022

An estimated kinds of plants, animals, protists and fungi live on Earth. Biodiversity loss is a major problem associated with human-made climate change. The current global rate of extinction is predicted to be nearly 100 times the baseline rate. But measuring those extinctions, or even accurately measuring the organisms that make up an ecosystem, is a challenge, since biodiversity assessment must include species from communities that cannot be observed by eye. 

Rachel with CALeDNA tubes with barcodes in archival ink to store all samples as frozen collections.
Rachel Meyer
Rachel Meyer uses CALeDNA tubes with barcodes in archival ink to store all samples
as frozen collections.

CALeDNA (pronounced cal-ee-DNA) is a partnership of scientists, universities and nonprofits focused on measuring ecosystems’ biodiversity and how ecosystems change over space and time. To do this, they isolate environmental DNA, or eDNA — which organisms shed into the ecosystem — from water, soil or sediment samples. They use a method called metabarcoding to amplify and sequence specific genetic loci including ribosomes, internal transcribed spacers, and cytochromes and then identify a list of species with eDNA in each sample. Sample collections are archived at University of California labs as a resource for future projects. 

The program emphasizes community involvement. CALeDNA organizes bioblitz events where community members and local organizations come together in the field to collect samples, photographs and geolocation data. The data from these projects are made publicly available through the and data exploration . 

Rachel Meyer is the CALeDNA director at the University of California, Santa Cruz. She is also an adjunct assistant professor and part of the led by Beth Shapiro and Ed Green. I sat down with Rachel to learn what CALeDNA was all about.

What ideas led to this program? What challenges are you facing?

The idea was to get a biodiversity signature from DNA in the environment that could be systematically collected around the globe to balance out biodiversity observations and improve predictive models. The proof of concept came out of work with ancient DNA. and collaborators including Beth Shapiro were the first to show that you could extract ancient and modern DNA from environmental samples, be it ice cores, soil and sediment, or bones. Getting biodiversity data from eDNA was working, and people were excited about it in Europe but not as much in the States. 

One of the reasons people have been reluctant to adopt eDNA in monitoring and modeling is people are skeptical about false positives and negatives. Another reason is we just don’t know how to put eDNA together with other data types to strengthen our analysis. When we started trying to analyze eDNA, the tools out there didn’t meet our needs. We had to string together a lot of different software. Then, when we finally got results of species in different samples, we saw different species from what people recorded with traditional observations like photos. When you get an answer you don’t expect, is that false? Or is there an eDNA realm we can’t see? We have been answering these questions slowly with pilot studies.

Fascinating! What led you to your position as the CALeDNA program director?

I went to a Department of Defense conference on environmental conflict in 2016, and they were talking about predicting environmental conditions that cause conflict around the globe. A lot of this is based around water. None of their models included biodiversity; they said it was too hard. I felt like I could contribute to this work, and this led me to start looking for biodiversity research jobs.

What are your goals, and how close do you think you are to achieving them?

There are some field pics she likes that she sent me but she's not in them.
Rachel Meyer
CALeDNA director Rachel Meyer works in the field.

We want to be able to measure biodiversity accurately and measure how it changes, and we want to integrate eDNA data with as many other kinds of data as we can.

I think we are still 10 years away from making this standard, but we are getting out of perpetual pilot mode. We are repeating our pipeline now — not building it anymore — so we can start to stack up the pilot projects and glean patterns. And we have recently received financial support to start co-analyzing eDNA with remote sensing climate data from NASA, or functional chemical diversity data, hydrological or biogeochemical data, and anything else under the sun, so we can make sense of changes in biodiversity patterns. We need to broaden our collaboration community, and that takes time. 

What do you mean by remote sensing and chemical diversity data?

Satellites can detect related species because they produce related spectral signatures, so you can map the community population of, for example, a forest canopy from space. You can detect stress responses from space. With models, you can map underground fungi from space. This is where we need to engage more with biochemists and molecular biologists. Let’s ask questions about the rules of life, evolution and ecology and the missing metabolic or cellular links! 

Wow! So what is the rate-limiting step to integrating all this data?

Honestly, it’s collecting reference sequence data for species and understanding the different things we can measure from our environmental collections. 70% of DNA sequences from our data sets will be tossed because we don’t know what species they are. 

There are more interesting questions we want to get into. We track taxa, but what about genes? What about the proteins and their conformation or responses to the environment? We are building better analysis tools and infrastructure to ask these kinds of questions, and we hope researchers will play with the nearly 5,000 samples we have already archived.

Community scientists and CALeDNA researchers collection samples.
Rachel Meyer
Community scientists and CALeDNA researchers collect samples.

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Jen Elana Quick-Cleveland

Jen Elana Quick-Cleveland is a postdoctoral research fellow at the Center for 麻豆传媒色情片 Biology of RNA at UC Santa Cruz, and serves on the ASBMB editorial advisory board.

Get the latest from ASBMB Today

Enter your email address, and we鈥檒l send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

How scientists identified a new neuromuscular disease
Feature

How scientists identified a new neuromuscular disease

Aug. 14, 2025

NIH researchers discover Morimoto鈥揜yu鈥揗alicdan syndrome, after finding shared symptoms and RFC4 gene variants in nine patients, offering hope for faster diagnosis and future treatments.

Unraveling cancer鈥檚 spaghetti proteins
Profile

Unraveling cancer鈥檚 spaghetti proteins

Aug. 13, 2025

MOSAIC scholar Katie Dunleavy investigates how Aurora kinase A shields oncogene c-MYC from degradation, using cutting-edge techniques to uncover new strategies targeting 鈥渦ndruggable鈥 molecules.

How HCMV hijacks host cells 鈥 and beyond
Profile

How HCMV hijacks host cells 鈥 and beyond

Aug. 12, 2025

Ileana Cristea, an ASBMB Breakthroughs webinar speaker, presented her research on how viruses reprogram cell structure and metabolism to enhance infection and how these mechanisms might link viral infections to cancer and other diseases.

Understanding the lipid link to gene expression in the nucleus
Profile

Understanding the lipid link to gene expression in the nucleus

Aug. 11, 2025

Ray Blind, an ASBMB Breakthroughs speaker, presented his research on how lipids and sugars in the cell nucleus are involved in signaling and gene expression and how these pathways could be targeted to identify therapeutics for diseases like cancer.

Receptor antagonist reduces age-related bone loss in mice
Journal News

Receptor antagonist reduces age-related bone loss in mice

Aug. 6, 2025

Receptor antagonist reduces bone loss and promotes osteoblast activity in aging mice, highlighting its potential to treat osteoporosis. Read more about this recent JBC paper.

Engineered fusion protein targets kiwifruit pathogen
Journal News

Engineered fusion protein targets kiwifruit pathogen

Aug. 6, 2025

Synthetic protein selectively kills kiwifruit pathogen, offering a promising biocontrol strategy for agriculture. Read more about this recent JBC paper.